Document Actions
News and Events
Up one levelWorking Group on New TB Drugs
The Working Group on New Drugs (WGND) is a network of experts committed to accelerating the development of effective and affordable new therapies for TB. The WGND functions as a forum for global collaborations and joint projects in this field. The WGND is one of the Stop TB Partnership's seven Working Groups.
International Standards for Tuberculosis Care (ISTC)
International Standards for Tuberculosis Care (ISTC), second edition. Tuberculosis Coalition for Technical Assistance, The Hague, 2009.
ISTC Handbook 2007
Handbook for Using the International Standards for Tuberculosis Care. Tuberculosis Coalition for Technical Assistance. The Hague, 2007.
TAG: 2009 Report on Tuberculosis Research Funding Trends, 2005–2008
Treatment Action Group. November 2009.
Empowering Communities for TB Advocacy: The TAG-ICW Model
Lessons learned from two years of capacity building for HIV treatment activists to integrate tuberculosis and TB/HIV collaborative activities into their advocacy work. Treatment Action Group. 2009.
Flat-Lined: How Flat NIH Funding Undermines Research on HIV, Tuberculosis, and Viral Hepatitis
By Lydia H. Guterman. Treatment Action Group. May 2009.
Pathways to Better Diagnostics for Tuberculosis: A blueprint for the development of TB diagnostics.
This publication aims to provide a comprehensive, well-referenced blueprint to guide researchers, clinicians, industry partners, academics, and TB controllers in all sectors in all aspects of TB diagnostics development, from concept to evaluation, implementation, scale-up, delivery and impact.
Project Profile: A Phase IIb efficacy trial to evaluate the protective efficacy of a booster MVA85A vaccination in healthy, HIV-infected adults in South Africa, Senegal and The Gambia.
Safety and immunogenicity of new vaccines capacity in sub-Saharan Africa. A five-year project funded by the EDCTP and led by Dr. Martin Ota, Medical Research Council (MRC), The Gambia
Grand Challenges: Point-of-Care Diagnostics Grant Opportunity
The Bill & Melinda Gates Foundation is now accepting letters of inquiry for a new grant program to develop point-of-care diagnostics for the developing world. Deadline February 16, 2010.
The Gates Foundation awards 76 new grants for innovative global health initiatives
GRAND CHALLENGES EXPLORATIONS ROUND 3: The Bill & Melinda Gates Foundation awards 76 grants for innovative and unconventional initiatives aiming to tackle global health challenges.
2nd European Congress of Immunology - ECI 2009
“Immunity for Life - Immunology for Health” - 2nd Joint Meeting of European National Societies of Immunology, Berlin September 13-16, 2009
Myco-Scopic View - Funding opportunities for Mycobacterial disease research
Read about funding opportunities of interest to the mycobacterial community in the "Myco-Scopic View", a newsletter published by the National Institute of Allergy and Infectious Diseases (NIAID).
TAG report 2009
Tuberculosis Research & Development: A Critical Analysis of Funding Trends, 2005-2006 - An Update
WHO TB Drug Resistance Global Report -No.4
26 FEBRUARY 2008 | WASHINGTON DC /GENEVA -- Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to a new report published today. The report presents findings from the largest survey to date on the scale of drug resistance in tuberculosis.
WHO TB REPORT 2008
WORLDWIDE EFFORTS TO CONFRONT TUBERCULOSIS ARE MAKING PROGRESS, BUT TOO SLOW. This report is WHO's twelfth annual report on global tuberculosis control in a series that started in 1997.
MSF Symposium on TB field Diagnostics
Abstracts from MSF Symposium on TB field Diagnostics "TB: DYING for a TEST!" held at Cape Town on Nov 7, 2007 prior to 38th World Conference on Lung Health of IUATLD.
Open Forum 3 — Key Issues in TB Drug Development
This two-day Open Forum was the third in a series of meetings aimed to raise and address key issues in TB drug development, with a special focus on regulatory affairs. Speaker presentations are now available for download.
Immunodiagnosis of tuberculosis: new questions, new tools
Come and discuss the most recent developments in biomarkers discovery, diagnostic clinical trials, latest assay technologies, and how discoveries in these fields can be translated into innovative tools for TB immunodiagnostics!
Integrated TB Database
Integrated TB Database Project (PI - Gary Schoolnik from Stanford University in collaboration with Broad Institute) funded last year by BMGF has opened their web site.